login
login

Europe Daily Bulletin No. 13048

22 October 2022
Contents Publication in full By article 23 / 23
NEWS BRIEFS / Health
European Commission authorises Spikevax vaccine adapted to combat SARS-CoV-2 sub-variants BA.4 and BA.5

21/10/2022 (Agence Europe)The European Commission authorised, on Thursday 20 October, the bivalent messenger RNA vaccine developed by the pharmaceutical company Moderna and adapted to combat not only the original SARS-CoV-2 strain but also two of its sub-variants of concern: BA.4 and BA.5 (Omicron). The Commission’s decision is based on the scientific assessment of the European Medicines Agency (EMA), which issued a favourable recommendation the same day (see EUROPE B13047A22). The...

Contents

EUROPEAN COUNCIL
SECTORAL POLICIES
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
INSTITUTIONAL
EXTERNAL ACTION
Russian invasion of Ukraine
NEWS BRIEFS